Generally, in thyroid cancer, there is an increase in inflammatory factors such as Nuclear factor kappa light chain enhancer of activated B lymphocytes (NF-κB) and C-Reactive Protein (CRP), which in turn causes the tumor to progress and worsen the patient’s condition [8–10]. This evidence concerns the gene CRP and neoplasm.